Non-targeted metabolomic analysis identifies unique metabolite profiles in Coffea arabica, suggesting diverse bioactive compounds.
This study presents a non-targeted metabolomic of different parts of Coffea arabica (bean, flower, leaf, cascara, and parchment) using liquid chromatography Orbitrap high-resolution mass spectrometry (LC-Orbitrap HRMS) and chemometrics. The total phenolic content (TPC), total flavonoid content (TFC), total terpenoid content (TTeC), and antioxidant activity were also determined. Leaf extract exhibited the highest TPC (129.54 ± 3.58 mg GAE/g) and TFC (28.47 ± 1.12 mg QE/g), whereas flower extract demonstrated the highest TTeC (581.67 ± 6.11 mg UAE/g). The highest antioxidant activity (measured using the DPPH assay) was found in leaf extract (IC50 34.93 ± 3.30 ppm), followed by bean extract (75.54 ± 4.35 ppm). Metabolite profiling using LC-HRMS revealed distinct chemical signatures across C. arabica parts, highlighting tissue-specific accumulation of primary and secondary metabolites. Partial least squares regression with discriminant analysis (PLS-DA) and hierarchical cluster analysis (HCA) effectively discriminated sample groups and identified key metabolites contributing to their variation. Variable importance for projection (VIP) analysis highlighted metabolites, such as caffeine, D-(-)-quinic acid, chlorogenic acid, flavonoids, and lipids, as key discriminating compounds. In conclusion, the integration of LC-HRMS metabolomics underscores the distinct metabolite profiles of Coffea arabica plants as potential sources of bioactive compounds and provides a foundation for future studies aimed at evaluating their bioavailability, safety, and potential functional applications.
No takes yet. Share an insight, caveat, or question.
Putri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: